MRO Magazine

Research and Markets: Investigation Report on China’s Nicergoline Market, 2010-2019 Available Now for Analysis


June 11, 2015
By Business Wire News

DUBLIN

Research and Markets (http://www.researchandmarkets.com/research/m8jbwl/investigation) has announced the addition of the “Investigation Report on China’s Nicergoline Market, 2010-2019” report to their offering.

Nicergoline is a kind of ergot alkaloid, which can dilate the brain’s blood vessels and improve the blood supply of the brain. It can block a- receptor and accelerate metabolism as well as reduce the resistance of the brain’s blood vessels and increase the blood flow and the usage of glucose to improve mental retardation. Nicergoline can also accelerate the metabolism of dopamine, enhance the nerve conduction, improve the mental and emotional abnormality, accelerate the synthesis of the protein in brain, effectively improve memory, recover the normal function of nerve cells, and entirely improve the clinic symptom of chronic brain dysfunction syndrome.

Nicergoline was first researched and produced by Pfizer Co., Ltd., which is widely used for many indications. It spread across the globe after launching to the market.

Market size of nicergoline and its share in anti- Alzheimer’s disease drug market is small as a drug used for 30 years. There are many substitutes and its product lifecycle is in recession. According to the author’s market research, the market size of nicergoline in sample hospitals was about CNY 89 million in 2010 and CNY 76 million in 2014.

In future years, China’s nicergoline market will shrink because of the competition of other types of anti- AD drugs like biopharmaceuticals. However, the low- end market demand for nicergoline still exists, the nicergoline drug market won’t disappear in a short time.

Through this report, readers can acquire the following information:

– Sales price of nicergoline in the hospital market in China

– Market Share of Major Nicergoline Manufacturers in China

– Patent Status of Nicergoline in China

– Market share of Nicergoline by dosage form in hospital market in China

– Prospects of China Nicergoline Market

The following are recommended to purchase this report:

– Manufacturers of drugs for cardiovascular disease and Alzheimer’s disease

– Investors Focusing on China’s Drug Market

For more information visit http://www.researchandmarkets.com/research/m8jbwl/investigation

About Research and Markets

Research and Markets is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Chemicals